Global Statistics

All countries
158,360,499
Confirmed
Updated on May 9, 2021 4:22 am
All countries
136,716,577
Recovered
Updated on May 9, 2021 4:22 am
All countries
3,297,902
Deaths
Updated on May 9, 2021 4:22 am
Sunday, May 9, 2021

Global Statistics

All countries
158,360,499
Confirmed
Updated on May 9, 2021 4:22 am
All countries
136,716,577
Recovered
Updated on May 9, 2021 4:22 am
All countries
3,297,902
Deaths
Updated on May 9, 2021 4:22 am
Molderizer and Safe Shield

India Coronavirus Dispatch: Covaxin info sheet skips mention of two risks

As cases grow, India’s vaccination campaign falters

BENGALURU, India (AP) — Since India opened vaccinations to all adults this month, hoping to tame a disastrous coronavirus surge sweeping across the...

Vaccine Side Effect? Norway Sounds Alarm As 23 Elderly Patients Die After Receiving Pfizer Vaccine

More than 30000 people have received the first shot of the Pfizer or Moderna coronavirus vaccine in the Scandinavian country since the end of...

Coronavirus latest news: Women disproportionately impacted by Covid, says Duchess of Sussex – Telegraph.co.uk

Coronavirus latest news: Women disproportionately impacted by Covid, says Duchess of Sussex  Telegraph.co.uk Source link




Covaxin info sheet finds no mention of two rare but known risks


Two rare but known risks find no mention in the third and fourth versions of the information sheet Bharat Biotech has shared with beneficiaries of Covaxin, according to a report in The Wire. The risks relate to antibody-dependent enhancement (ADE) and vaccine-associated enhanced respiratory disease (VAERD). This is a source of concern as the recipients are expected to give their informed consent to getting the shot after reading the information sheet. Read more here


Covaxin a ‘buffet’ vaccine that can tackle mutations: Top virologist





Covaxin, manufactured by Hyderabad-based Bharat Biotech, is a broad spectrum “buffet vaccine” which will be effective against all mutations of Covid-19, compared to other “a la carte” inoculants that will need changes, a top virologist told ThePrint. Covaxin will work against all mutations as it produces a broad immune response where “one or the other” antibody produced will eventually neutralize the virus, Dr V. Ravi, former dean, basic sciences, National Institute of Mental Health and Neurosciences (NIMHANS) told ThePrint. Read more here


Why Covid-19 vaccines are not for pregnant women


The immune system of the body and how it responds to infections overall is altered by pregnancy, which can at times be reflected in more severe symptoms as well, according to a report in The Indian Express. This applies to Covid-19 infections as well. Experts have said pregnant or lactating women have not been included in any Covid-19 trial. Therefore, this group should not receive the vaccine at this time. This is also part of the advisory put out by the central health ministry. Read more here


Covaxin, Covishield safe for those on blood thinners: ICMR chief


Contrary to what the factsheets for Covaxin and Covishield say, there is no problem in administering the two vaccines to those on blood thinners such as aspirin and clopidogrel, Indian Council of Medical Research (ICMR) Director-General Dr Balram Bhargava said Thursday, according to a report in ThePrint. The manufacturers of both the vaccines Bharat Biotech and Serum Institute of India have approached the drug controller to make the changes to the factsheets. Covaxin’s current factsheet says those who are on blood thinners or have bleeding disorders cannot get the shot. Covisheld’s existing factsheet asks vaccine beneficiaries to inform their physicians in advance. Read more here

OPINION: Vaccine hesitancy cannot be tackled by drugmakers alone


The central and state governments together with health policymakers need to play a key role in educating the general public about vaccines. Hesitancy cannot be tackled just by pharma firms alone, said Santanu Pramanik, deputy director at NCAER National Data Innovation Centre, and Sonalde Desai, director at NCAER NDIC, in an opinion piece for The Indian Express. Policies must be implemented to address the health and financial risks associated with any adverse events. Training needs to be imparted to health providers in answering questions, identifying and treating potential side-effects. Information about vaccination schedule, locations, regimen, dealing with adverse events should be readily available. Read more here

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

As cases grow, India’s vaccination campaign falters

BENGALURU, India (AP) — Since India opened vaccinations to all adults this month, hoping to tame a disastrous coronavirus surge sweeping across the...

Vaccine Side Effect? Norway Sounds Alarm As 23 Elderly Patients Die After Receiving Pfizer Vaccine

More than 30000 people have received the first shot of the Pfizer or Moderna coronavirus vaccine in the Scandinavian country since the end of...

Related Articles

As cases grow, India’s vaccination campaign falters

BENGALURU, India (AP) — Since India opened vaccinations to all adults this month, hoping to tame a disastrous coronavirus surge sweeping across the...

Vaccine Side Effect? Norway Sounds Alarm As 23 Elderly Patients Die After Receiving Pfizer Vaccine

More than 30000 people have received the first shot of the Pfizer or Moderna coronavirus vaccine in the Scandinavian country since the end of...